Daniel Ben-Mordechay: Portal Vein Thrombosis Every POCUS User Should Recognize
Daniel Ben-Mordechay, Chief Executive Officer at Orimed GTD, shared a post on LinkedIn:
”Portal Vein Thrombosis: A Diagnosis Every POCUS User Should Recognize
Portal vein thrombosis (PVT) is a potentially serious vascular condition that can compromise hepatic blood flow and lead to portal hypertension, intestinal ischemia, or progressive liver dysfunction if not recognized and managed promptly.
Ultrasound is often the first-line imaging modality and plays a pivotal role in the initial evaluation.
On B-mode ultrasound, the thrombus typically appears as echogenic material within the lumen of the portal vein. In acute cases, the thrombus may be hypoechoic, making it more difficult to detect. The vein may appear dilated, and the thrombus can partially or completely occlude the vessel.
Color Doppler is essential in the assessment of suspected PVT.
A thrombosed segment demonstrates absent or markedly reduced intraluminal flow, while Spectral Doppler confirms the loss or significant alteration of normal hepatopetal portal venous flow.
Common risk factors include:
- Liver cirrhosis.
- Hepatocellular carcinoma and other malignancies.
- Hypercoagulable disorders.
- Pancreatitis.
- Intra-abdominal infection or inflammation.
- Recent abdominal surgery or trauma.
POCUS can rapidly raise suspicion for portal vein thrombosis, particularly in patients with unexplained abdominal pain, signs of portal hypertension, or known risk factors. However, it is important to remember that POCUS is a screening tool. Suspected PVT should always be confirmed with a comprehensive Doppler examination and, when clinically indicated, contrast-enhanced CT or MRI.
Understanding the normal sonographic appearance of the portal vein is the foundation of diagnosis. Equally important is recognizing abnormal intraluminal echoes, absent Doppler flow, and associated secondary findings. Early detection can significantly influence patient management and improve clinical outcomes.
Have you encountered portal vein thrombosis during your ultrasound examinations? Share your experience and teaching tips in the comments.
Other posts featuring Daniel Ben-Mordechay on Hemostasis Today.
-
Jul 21, 2026, 03:19Where Does Stroke Treatment Go Next on The Latest ESOC 2026 TV Studio Session – ESO
-
Jul 21, 2026, 03:09Francesca Palandri: New Insights Into Anemia Management in Myelofibrosis
-
Jul 21, 2026, 01:57A New Approach to Understanding Plasmin Generation and Fibrinolysis – RPTH Journal
-
Jul 21, 2026, 01:52Maria Diaz Alonso: Delivering My First International Oral Presentation at ISTH 2026
-
Jul 21, 2026, 01:44Megan Preece: Presenting New Research on Antiphospholipid Syndrome at ISTH 2026
-
Jul 21, 2026, 01:28Dhamirah Nazihah Mohd Nasiruddin: A Milestone in My Haemostasis and Thrombosis Journey at ISTH 2026
-
Jul 21, 2026, 00:55Anita Brikman on PPTA’s First-Half 2026 Achievements
-
Jul 21, 2026, 00:50Caitlin Raymond: Can Therapeutic Plasma Exchange Reduce Microplastics?
-
Jul 21, 2026, 00:46Yohei Hisada: Science, Collaboration, and New Beginnings at ISTH 2026